Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Mike2188
    Member
    • Oct 2013
    • 27

    #1

    Conceptual question of validity of transcriptional profiling

    I have a question regarding data handling of RNA-seq experiments and even microarray I guess.

    How do these methods take total total cellular expression into account?

    For instance say I was looking at the global analysis of the transcriptome of whole arabidopsis early seed vs. mature seed. One would expect the overall expression of the late dormant seed to be low.

    Let's pretend there are only 5 genes in my seed, A, B, C, D, and E. Here are the absolute expression values.

    Early:
    A: 10 transcripts/cell
    B: 10 transcripts/cell
    C: 20 transcripts/cell
    D: 40 transcripts/cell
    E: 20 transcripts/cell

    Late:
    A: 1 transcript/cell
    B: 1 transcript/cell
    C: 2 transcript/cell
    D: 4 transcript/cell
    E: 2 transcript/cell

    Although Late has lower absolute expression values, if I took 5 micrograms of total RNA from both to prepare a library, each sample would have 10% transcript A, 10% transcript B, 20% transcript C, 40% transcript D, and 20% transcript E - it would just take more late seeds to produce that much RNA.

    If differential expression was performed on each of these with no manipulation to the data, it would appear as if the levels of expression of these genes within each tissue are the same right?

    How is this corrected for in analyses? Is a housekeeping gene generally used to normalize expression patterns, and are housekeeping genes even useful when looking at cells with dormant expression and limited proliferation?

    Let's take a look at one more scenario. Instead lets say I am comparing early seed to maturing seed, in which a family of transcripts coding for storage proteins are highly highly expressed.

    Early:
    A: 10 transcripts/cell
    B: 10 transcripts/cell
    C: 20 transcripts/cell
    D (storage protein): 40 transcripts/cell
    E (storage protein): 20 transcripts/cell

    Late:
    A: 10 transcripts/cell
    B: 10 transcripts/cell
    C: 20 transcripts/cell
    D (storage protein): 400 transcripts/cell
    E (storage protein): 200 transcripts/cell

    In this example, if I were to take both libraries and perform sequencing, A, B, and C would appear to be downregulated in late seed, even though their relative expression is the same.

    So basically my question is, are we actually just measuring the relative proportions of transcripts in transcriptional profiling experiments, or is there some sort of correction method that allows us to speculate actual absolute values? Sorry for the long post. Wanted to be clear.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    In cases where you suspect global transcriptional amplification/repression to play a role you need to use spike-ins. This is also true for single-cell sequencing, essentially for the reasons you outlined. Normally this isn't the case and you can simply use the fact that most genes aren't changed for normalization.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Today, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    67 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    47 views
    0 reactions
    Last Post SEQadmin2  
    Working...